Evolving for Tomorrow’s Challenges
2020 has led the industry to an inflection point — healthcare systems’ resilience and agility are being tested, challenging pre-pandemic priorities under unprecedented resource constraints. This has highlighted opportunities and challenges in HEOR methods, practices, and application including our ability to respond effectively.
The shift to digital and increasing availability of real-world data allow for the rapid generation of evidence and value measurement. As we rethink how we deliver healthcare in the new normal, EVERSANA is committed to improving health outcomes by addressing value challenges with evidence-driven, real-world evidence.
We’re proud to present the following at ISPOR 2021, taking place virtually May 17-20:
An Umbrella Review Comparing the Safety and Effectiveness of FLACS with Manual Cataract Surgery
Procedure Cost-Comparison Analysis of Liquid Embolic System Techniques Using EvOH and n-BCA in the Embolization of Brain Arteriovenous Malformations
Predictive Models Leveraging Machine Learning and Real-World Data for Early Diagnosis: An Application in Amyotrophic Lateral Sclerosis